Human Thrombin Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Product (Bovine Thrombin, Human Thrombin, Recombinant Thrombin); Dosage Form (Powder Form, Solution Form, Others); End User (Hospitals, Diagnostics Centers and Clinics, Academics and Research Institutes)
Report Code: TIPRE00008178 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Thrombin is a serine protease enzyme that is encoded by a particular gene named F2 and is used to convert soluble fibrinogen into insoluble fibrin. Human thrombin is a sterile solution, having pH 6.8-7.2, containing highly purified human thrombin for the activation of clotting. It is used in various medical surgeries in the management of uncontrolled bleeding. R&D applications include several research activities such as protein-structure analysis, in vitro study, coagulation research, biochemical research, and medical research.
MARKET DYNAMICS
The human thrombin market is anticipated to rise in adoption in various research and diagnostic applications. However, the increasing hemostatic use of thrombin-based products during surgeries has driven the demand for thrombin in the hospital segment. Moreover, the growing adoption of hemostats in excessive bleeding during the surgical procedure is expected to benefit the growth of the market in the forecast period.
MARKET SCOPE
The "Human Thrombin Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in human thrombin market with detailed market segmentation by product, dosage form, end user and geography. The human thrombin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in human thrombin market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The human thrombin market is segmented on the basis of product, dosage form and end user. Based on product the market is segmented as bovine thrombin, human thrombin and recombinant thrombin. On the basis of dosage form the market is categorized as powder form, solution form and others. On the basis of end user the market is categorized as hospitals, diagnostics centers & clinics and academics and research institutes.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in human thrombin market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The human thrombin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting human thrombin market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the human thrombin market in these regions.
The report covers key developments in the in human thrombin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in human thrombin market are anticipated to have lucrative growth opportunities in the future with the rising demand for in human thrombin market in the global market. Below mentioned is the list of few companies engaged in the human thrombin market.
The report also includes the profiles of key in human thrombin market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Thrombin is a serine protease enzyme that is encoded by a particular gene named F2 and is used to convert soluble fibrinogen into insoluble fibrin. Human thrombin is a sterile solution, having pH 6.8-7.2, containing highly purified human thrombin for the activation of clotting. It is used in various medical surgeries in the management of uncontrolled bleeding. R&D applications include several research activities such as protein-structure analysis, in vitro study, coagulation research, biochemical research, and medical research.
MARKET DYNAMICS
The human thrombin market is anticipated to rise in adoption in various research and diagnostic applications. However, the increasing hemostatic use of thrombin-based products during surgeries has driven the demand for thrombin in the hospital segment. Moreover, the growing adoption of hemostats in excessive bleeding during the surgical procedure is expected to benefit the growth of the market in the forecast period.
MARKET SCOPE
The "Human Thrombin Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in human thrombin market with detailed market segmentation by product, dosage form, end user and geography. The human thrombin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in human thrombin market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The human thrombin market is segmented on the basis of product, dosage form and end user. Based on product the market is segmented as bovine thrombin, human thrombin and recombinant thrombin. On the basis of dosage form the market is categorized as powder form, solution form and others. On the basis of end user the market is categorized as hospitals, diagnostics centers & clinics and academics and research institutes.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in human thrombin market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The human thrombin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting human thrombin market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the human thrombin market in these regions.
The report covers key developments in the in human thrombin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in human thrombin market are anticipated to have lucrative growth opportunities in the future with the rising demand for in human thrombin market in the global market. Below mentioned is the list of few companies engaged in the human thrombin market.
The report also includes the profiles of key in human thrombin market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AMRESCO Inc.
- Baxter International, Inc.
- Bayer AG
- BD Biosciences
- CSL Behring
- Life Technologies Corporation
- Pfizer Inc.
- PromoCell GmbH
- Sigma-Aldrich Corporation
- Vitrolife AB
The List of Companies
1. AMRESCO Inc.
2. Baxter International, Inc.
3. Bayer AG
4. BD Biosciences
5. CSL Behring
6. Life Technologies Corporation
7. Pfizer Inc.
8. PromoCell GmbH
9. Sigma-Aldrich Corporation
10. Vitrolife AB
1. AMRESCO Inc.
2. Baxter International, Inc.
3. Bayer AG
4. BD Biosciences
5. CSL Behring
6. Life Technologies Corporation
7. Pfizer Inc.
8. PromoCell GmbH
9. Sigma-Aldrich Corporation
10. Vitrolife AB
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount